Interestingly, MLKL significantly accumulated in nucleus of MM cells treated with DHA, EPA and bortezomib (Figure 7B) and MLKL nuclear translocation was also evidenced by immunocytochemistry analysis (Figures 7A, C). The gene discussed is MLKL; the disease is Miyoshi myopathy.